Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Ann Surg. 2023 Jan 10;277(2):e339–e345. doi: 10.1097/SLA.0000000000005332

Table 2.

Proportion of patients with lymph node metastasis (pN-positive) according to differentiation, tumor size, and lymphovascular invasion 31.

a
No LVI LVI
Differentiation Tumor size Total pN-positive Total pN-positive
Well or moderate ≤ 2 cm 594 53 (8.9%) 134 20 (14.9%)
≤ 3 cm 971 121 (12.5%) 241 47 (19.5%)
> 3 cm 518 134 (25.9%) 156 71 (45.5%)
Poor ≤ 2 cm 408 58 (14.2%) 102 36 (35.3%)
≤ 3 cm 675 119 (17.6%) 177 64 (36.2%)
> 3 cm 380 120 (31.6%) 80 41 (51.2%)
b
No LVI LVI
Differentiation Tumor size Total pN-positive Total pN-positive
Well ≤ 1 cm 63 1 (1.6%) 11 2 (18.2%)
≤ 2 cm 200 6 (3.0%) 43 3 (7.0%)
≤ 3 cm 296 10 (3.4%) 74 9 (12.2%)
> 3 cm 138 25 (18.1%) 55 19 (34.5%)
Moderate ≤ 1 cm 106 12 (11.3%) 20 2 (10.0%)
≤ 2 cm 394 47 (11.9%) 91 17 (18.7%)
≤ 3 cm 675 111 (16.4%) 167 38 (22.8%)
> 3 cm 380 109 (28.7%) 101 52 (51.5%)

a, Well or moderately vs. poorly differentiated tumors. Bolded entries indicate patients meeting criteria for definitive treatment by endoscopic resection according to Japanese (≤ 3 cm) and NCCN (≤ 2 cm) criteria. b, Well vs. moderately differentiated tumors. Italicized entries indicate patients meeting above criteria but excluding moderate differentiation.